Glycobiology, 2000, Vol. 10, No. 7 649-658
© 2000 Oxford University Press
Influenza virus infection of desialylated cells
2Department of Biochemistry & Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190, USA, and 3Microbiology Graduate Program, Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
Sialic acid has long been considered to be the sole receptor for influenza virus. The viral hemagglutinin (HA) is known to bind cell surface sialic acid, and sialic acids on viral glycoproteins are cleaved by the viral neuraminidase (NA) to promote efficient release of progeny virus particles. However, NWS-Mvi, a mutant virus completely lacking NA, grows well in MDCK cells continuously treated with exogenous neuraminidase (sialidase). Exogenous sialidase quantitatively releases all sialic acids from purified glycoproteins and glycolipids of MDCK cells and efficiently removes surface sialic acid from intact cells. Binding of NWS-Mvi and parent influenza viruses to MDCK cells is indistinguishable, and is only partially reduced by sialidase treatment of the cells. Both mutant and wild-type viruses enter enzymatically desialylated cells and initiate transcription. The ability of influenza A reassortant viruses to infect desialylated cells is shared by recent H3N2 clinical isolates, suggesting that this may be a general property of influenza A viruses. We propose that influenza virus infection can result from sialic acid–independent receptors, either directly or in a multistage process. When sialic acid is present, it may act to enhance virus binding to the cell surface to increase interaction with secondary receptors to mediate entry. Understanding virus entry will be critical to further efforts in infection control and prevention.
1 To whom correspondence should be addressed at: Department of Biochemistry & Molecular Biology, University of Oklahoma Health Sciences Center, BMSB 840, P.O. Box 26901, Oklahoma City, OK 73190
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. W. Y. Chan, M. C. W. Chan, A. C. N. Wong, R. Karamanska, A. Dell, S. M. Haslam, A. D. L. Sihoe, W. H. Chui, G. Triana-Baltzer, Q. Li, et al. DAS181 Inhibits H5N1 Influenza Virus Infection of Human Lung Tissues Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3935 - 3941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Bateman, M. G. Busch, A. I. Karasin, N. Bovin, and C. W. Olsen Amino Acid 226 in the Hemagglutinin of H4N6 Influenza Virus Determines Binding Affinity for {alpha}2,6-Linked Sialic Acid and Infectivity Levels in Primary Swine and Human Respiratory Epithelial Cells J. Virol., August 15, 2008; 82(16): 8204 - 8209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza J. Antimicrob. Chemother., August 1, 2008; 62(2): 219 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Nicholls, L. M. Aschenbrenner, J. C. Paulson, E. R. Campbell, M. P. Malakhov, D. F. Wurtman, M. Yu, and F. Fang Comment on: Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza J. Antimicrob. Chemother., August 1, 2008; 62(2): 426 - 428. [Full Text] [PDF]
|
|
|
|
|
|
H. Zhang Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza--author's response J. Antimicrob. Chemother., August 1, 2008; 62(2): 428 - 429. [Full Text] [PDF]
|
|
|
|
|
|
M. P. Malakhov, L. M. Aschenbrenner, D. F. Smee, M. K. Wandersee, R. W. Sidwell, L. V. Gubareva, V. P. Mishin, F. G. Hayden, D. H. Kim, A. Ing, et al. Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1470 - 1479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Mishin, D. Novikov, F. G. Hayden, and L. V. Gubareva Effect of Hemagglutinin Glycosylation on Influenza Virus Susceptibility to Neuraminidase Inhibitors J. Virol., October 1, 2005; 79(19): 12416 - 12424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. C. Chu and G. R. Whittaker Influenza virus entry and infection require host cell N-linked glycoprotein PNAS, December 28, 2004; 101(52): 18153 - 18158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Jones, B. Yazzie, and C. R. Middaugh Polyanions and the Proteome Mol. Cell. Proteomics, August 1, 2004; 3(8): 746 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Caruso, M. Cavaldesi, M. Gentile, O. Sthandier, P. Amati, and M.-I. Garcia Role of sialic acid-containing molecules and the {alpha}4{beta}1 integrin receptor in the early steps of polyomavirus infection J. Gen. Virol., November 1, 2003; 84(11): 2927 - 2936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Miller and E. M. Anders Virus-cell interactions in the induction of type 1 interferon by influenza virus in mouse spleen cells J. Gen. Virol., January 1, 2003; 84(1): 193 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Gulati, C.-C. Hwang, L. Venkatramani, S. Gulati, S. J. Stray, J. T. Lee, W. G. Laver, A. Bochkarev, A. Zlotnick, and G. M. Air Antibody Epitopes on the Neuraminidase of a Recent H3N2 Influenza Virus (A/Memphis/31/98) J. Virol., December 1, 2002; 76(23): 12274 - 12280. [Abstract] [Full Text] [PDF]
|
|